価格表

在庫・価格 : 2026年04月06日 18時40分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human NKp30 MAb (Clone 210845)
データシート
MAB1849-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥25,000 1個 追加

在庫・価格 : 2026年04月06日 18時40分 現在

Anti-Human NKp30 MAb (Clone 210845)

  • 商品コード:MAB1849-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥25,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Kim N et al. PVR and ICAM-1 on Blast Crisis CML Stem and Progenitor Cells with TKI Resistance Confer Susceptibility to NK Cells. Cancers (Basel) 2020 Jul;12(7)
Kim N et al
2020/01/01
Species: Human, Applications: Flow Cytometry PubMed
2 Shi J et al. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Blood 2008 Feb;111(3):1309-17
Shi J et al
2008/01/01
Species: Human, Applications: Neutralization PubMed
3 Herrmann J et al. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands. J. Biol. Chem. 2014 Jan;289(2):765-77
Herrmann J et al
2014/01/01
Species: Human, Applications: Flow Cytometry PubMed
4 Djaoud Z et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells. J. Exp. Med. 2017 Jun;214(6):1827-1841
Djaoud Z et al
2017/01/01
Species: Human, Applications: Neutralization PubMed
5 Warren HS et al. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. J. Immunol. 2005 Jul;175(1):207-12
Warren HS et al
2005/01/01
Species: Human, Applications: Flow Cytometry PubMed
6 Warren HS et al. A novel binding assay to assess specificity of monoclonal antibodies. J. Immunol. Methods 2005 Oct;305(1):33-8
Warren HS et al
2005/01/01
Species: Human, Applications: Epitope Mapping PubMed
  • No.: 1
  • 文献情報:
    Kim N et al. PVR and ICAM-1 on Blast Crisis CML Stem and Progenitor Cells with TKI Resistance Confer Susceptibility to NK Cells. Cancers (Basel) 2020 Jul;12(7)
    Kim N et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Shi J et al. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Blood 2008 Feb;111(3):1309-17
    Shi J et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Herrmann J et al. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands. J. Biol. Chem. 2014 Jan;289(2):765-77
    Herrmann J et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Djaoud Z et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells. J. Exp. Med. 2017 Jun;214(6):1827-1841
    Djaoud Z et al
    2017/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Warren HS et al. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. J. Immunol. 2005 Jul;175(1):207-12
    Warren HS et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Warren HS et al. A novel binding assay to assess specificity of monoclonal antibodies. J. Immunol. Methods 2005 Oct;305(1):33-8
    Warren HS et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Epitope Mapping
  • 参照:
    PubMed